EUVIMEDEUVIMED entdecken
Crossref

An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae

Chang He, Hongzhi Luo, Can Liu, Shixu Liu, Xiao Luo, Samah A. Loutfy, Arzum Erdem, Minkyu Shin, Hiroya Abe, Jeong-Woo Choi, Bo Gong, Shan Liu und 1 weitere

BME Frontiers · 16.11.2026

DOI: 10.34133/bmef.0348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 16.11.2026. Verfasst von Chang He und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

He, C., Luo, H., Liu, C., Liu, S., Luo, X., Loutfy, S. A., Erdem, A., Shin, M., Abe, H., Choi, J., Gong, B., Liu, S., & Li, C. (2026). An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae. BME Frontiers. https://doi.org/10.34133/bmef.0348

Vancouver

He C, Luo H, Liu C, Liu S, Luo X, Loutfy SA, et al. An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae. BME Frontiers. 2026. doi:10.34133/bmef.0348

BibTeX
@article{He2026,
  author = {He, Chang and Luo, Hongzhi and Liu, Can and Liu, Shixu and Luo, Xiao and Loutfy, Samah A. and Erdem, Arzum and Shin, Minkyu and Abe, Hiroya and Choi, Jeong-Woo and Gong, Bo and Liu, Shan and Li, Chenzhong},
  title = {An Integrated Microfluidic CRISPR-Cas12a Platform for Robust POCT of Mycoplasma pneumoniae},
  journal = {BME Frontiers},
  year = {2026},
  doi = {10.34133/bmef.0348}
}
Kostenlos starten →